Mark Jon Olsen

Person

Phoenix, AZ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Isotopically-stabilized tetronimide compounds
- Patent number 11,897,857
- Issue date Feb 13, 2024
- Midwestern University
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using monoclonal antibodies targeting epitopes of ASPH
- Patent number 11,236,178
- Issue date Feb 1, 2022
- Midwestern University
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies targeting epitopes of ASPH
- Patent number 10,961,320
- Issue date Mar 30, 2021
- Midwestern University
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isotopically-stabilized tetronimide compounds
- Patent number 10,961,211
- Issue date Mar 30, 2021
- Midwestern University
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of beta-hydroxylase for treatment of cancer
- Patent number 10,787,445
- Issue date Sep 29, 2020
- Midwestern University
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of β-hydroxylase for treatment of cancer
- Patent number 10,710,995
- Issue date Jul 14, 2020
- Rhode Island Hospital
- Jack R. Wands
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of β-hydroxylase for treatment of cancer
- Patent number 10,351,555
- Issue date Jul 16, 2019
- Midwestern University
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of beta-hydroxylase for treatment of cancer
- Patent number 10,106,532
- Issue date Oct 23, 2018
- Midwestern University
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of beta-hydroxylase for treatment of cancer
- Patent number 9,771,356
- Issue date Sep 26, 2017
- Rhode Island Hospital
- Jack R. Wands
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
Inhibitors of Beta-Hydoxylase for Treatment of Cancer
- Publication number 20220251076
- Publication date Aug 11, 2022
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH
- Publication number 20220162341
- Publication date May 26, 2022
- MIDWESTERN UNIVERSITY
- Mark Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS
- Publication number 20210094927
- Publication date Apr 1, 2021
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TARGETING ASPARTATE BETA-HYDROXYLASE SUPPRESSES TUMOR MALIGNANCY AN...
- Publication number 20210052561
- Publication date Feb 25, 2021
- Rhode Island Hospital
- Jack R. Wands
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of Beta-Hydroxylase for Treatment of Cancer
- Publication number 20210032233
- Publication date Feb 4, 2021
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH
- Publication number 20210009713
- Publication date Jan 14, 2021
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
- Publication number 20200361925
- Publication date Nov 19, 2020
- Rhode Island Hospital
- Jack R. Wands
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isotopically-Stabilized Tetronimide Compounds
- Publication number 20200262804
- Publication date Aug 20, 2020
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANITIBODIES TARGETING EPITOPES OF ASPH
- Publication number 20190382506
- Publication date Dec 19, 2019
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Beta-Hydroxylase for Treatment of Cancer
- Publication number 20190300519
- Publication date Oct 3, 2019
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
- Publication number 20190002453
- Publication date Jan 3, 2019
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER
- Publication number 20180237427
- Publication date Aug 23, 2018
- Rhode Island Hospital
- Jack R. Wands
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of Beta-Hydroxylase for Treatment of Cancer
- Publication number 20180009798
- Publication date Jan 11, 2018
- MIDWESTERN UNIVERSITY
- Mark Jon Olsen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Inhibitors of Beta-Hydroxylase for Treatment of Cancer
- Publication number 20150210677
- Publication date Jul 30, 2015
- MIDWESTERN UNIVERSITY
- Jack R. Wands
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Mark Jon Olsen

Person

Patents Grantslast 30 patents

Isotopically-stabilized tetronimide compounds

Methods of using monoclonal antibodies targeting epitopes of ASPH

Monoclonal antibodies targeting epitopes of ASPH

Isotopically-stabilized tetronimide compounds

Inhibitors of beta-hydroxylase for treatment of cancer

Inhibitors of β-hydroxylase for treatment of cancer

Inhibitors of β-hydroxylase for treatment of cancer

Inhibitors of beta-hydroxylase for treatment of cancer

Inhibitors of beta-hydroxylase for treatment of cancer

Patents Applicationslast 30 patents

Inhibitors of Beta-Hydoxylase for Treatment of Cancer

METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH

ISOTOPICALLY-STABILIZED TETRONIMIDE COMPOUNDS

TARGETING ASPARTATE BETA-HYDROXYLASE SUPPRESSES TUMOR MALIGNANCY AN...

Inhibitors of Beta-Hydroxylase for Treatment of Cancer

METHODS OF USING MONOCLONAL ANTIBODIES TARGETING EPITOPES OF ASPH

INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER

Isotopically-Stabilized Tetronimide Compounds

MONOCLONAL ANITIBODIES TARGETING EPITOPES OF ASPH

Inhibitors of Beta-Hydroxylase for Treatment of Cancer

INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER

INHIBITORS OF BETA-HYDROXYLASE FOR TREATMENT OF CANCER

Inhibitors of Beta-Hydroxylase for Treatment of Cancer

Inhibitors of Beta-Hydroxylase for Treatment of Cancer